Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial
Key Points
Key points are not available for this paper at this time.
Abstract
European Union Clinical Trials Register, EU 2017-004641-25.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial | Synapse